ALX Oncology Inc. (ALXO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

ALX Oncology Inc.

NASDAQ: ALXO · Real-Time Price · USD
1.87
0.08 (4.47%)
At close: Sep 26, 2025, 3:59 PM
1.88
0.53%
After-hours: Sep 26, 2025, 07:29 PM EDT

ALX Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
17.57M 22.41M 48.82M 363.67M
Short-Term Investments
110.19M 160.33M 217.38M n/a
Long-Term Investments
3.52M 35.41M 16.7M n/a
Other Long-Term Assets
267K 7.64M 9.01M 9.69M
Receivables
892K 1M 1M n/a
Inventory
n/a n/a -17.7M n/a
Other Current Assets
5.7M 4.92M 16.7M n/a
Total Current Assets
134.35M 188.66M 270.97M 367.02M
Property-Plant & Equipment
9.63M 10.84M 9.81M 3.47M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
13.42M 53.89M 35.52M 13.16M
Total Assets
147.78M 242.55M 306.49M 380.18M
Account Payables
4.5M 8.59M 8.07M 3.76M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
435K 1.57M 1.04M 742K
Other Current Liabilities
7.88M 17.65M 14.46M 444K
Total Current Liabilities
18.5M 36M 28.32M 15.29M
Long-Term Debt
9.47M 9.64M 9.39M n/a
Other Long-Term Liabilities
1.03M 1.22M 5.31M 1.84M
Total Long-Term Liabilities
15.66M 16.84M 14.7M 1.84M
Total Liabilities
34.16M 52.84M 43.02M 17.13M
Total Debt
9.9M 17.2M 10.43M 742K
Book Value
113.62M 189.71M 263.46M 363.05M
Book Value Per Share
2.18 4.41 6.47 9.01
Common Stock
53K 50K 41K 41K
Retained Earnings
-621.12M -486.27M -325.47M -201.99M
Comprehensive Income
275K 256K -845K n/a
Shareholders Equity
113.62M 189.71M 263.46M 363.05M
Total Investments
113.71M 195.74M 234.08M n/a